Biotech Values

[DewDiligence]

1Q22 worldwide Botox sales=$1.255B, -3% QoQ*, +24% YoY:

https://news.abbvie.com/news/press-releases/abbvie-reports-first-quarter-2022-financial-results.htm

• US therapeutic: $500M (-11% QoQ*, +17% YoY)
• US cosmetic: $413M (+4% QoQ*, +36% YoY)
--
US total: $913M (55% therapeutic; 45% cosmetic) was 73% of worldwide total


• Ex-US therapeutic: $114M (+4% QoQ*, +17% YoY)
• Ex-US cosmetic: $228M (flat QoQ*, +39% YoY)
--
Ex-US total: $342M (33% therapeutic; 67% cosmetic) was 27% of worldwide total


*Botulinum-toxin sales are seasonally stronger during the second and fourth calendar quarters than the first and third calendar quarters.